NCT04419181 2025-10-14Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast CancerUniversity of RochesterPhase 2 Withdrawn
NCT07043725 2025-09-23A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3 Recruiting544 enrolled